Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
3
Neutral
8
Bullish
3
Bearish
4
Neutral
32
Bullish
10
Bearish
1
Neutral
24
Bullish
7
Raymed Labs Limited is a pharmaceutical company focusing on injectables and ophthalmic solutions, founded in 1994.
The company has excelled in the ophthalmology industry, leveraging robust marketing infrastructure for wide geographic reach.
It specializes in preservative-free ophthalmic dosages, particularly for conjunctivitis and glaucoma, using advanced technologies.
Raymed has expanded its product offerings, effectively converting formulations from suspension to solution for better absorption and patient compliance.
The company operates world-class, multi-facility manufacturing sites, certified by WHO-GMP and various international bodies like ANVISA and NAFDAC.
Packaging
Packaging - Others
2 Cr
Moderate Risk
—
14.6
—
—
3.83
2.88
Sales CAGR
1Y
—
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
-80.00%
3Y
—
5Y
—
10Y
—
ROE
TTM
10.46%
3Y
6.20%
5Y
5.26%
10Y
4.11%
ROCE
TTM
76.51%
3Y
265.19%
5Y
23.19%
10Y
6.46%
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Performance
MARKET LEADER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Neutral
Risk
LOW RISK
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
11.94 | 11 Cr | 20.93 | 0.61 | 0.00 | 2.91 | 5.91 | 0.67 | |
4.95 | 9 Cr | 12.07 | 0.27 | 0.00 | -0.07 | 2.42 | -0.03 | |
16.24 | 7 Cr | — | 0.00 | 0.00 | 12.08 | -16.00 | -3.85 | |
20.55 | 6 Cr | 11.95 | 0.00 | 0.00 | -15.25 | -38.65 | 31.68 | |
11.98 | 4 Cr | — | 1.16 | 0.00 | -0.58 | -0.55 | -0.58 | |
3.83 | 2 Cr | — | 0.00 | 0.00 | 10.46 | 76.51 | -280.00 |
Market Cap
₹ 2 Cr
P/E
—
